Page - (000203) - in Biomedical Chemistry: Current Trends and Developments

Miller, G. W., R. R. Gainetdinov, et al. (1999). Dopamine transporters and neuronal injury. Trends in Pharmacological Sciences, 20(10), 424-429. Minkeviciene, R., S. Rheims, et al. (2009). Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. The Journal of Neuroscience, 29(11), 3453-3462. Mody, I. and R. A. Pearce (2004). Diversity of inhibitory neurotransmission through GABA(A) receptors. Trends in Neurosciences, 27(9), 569-575. Mogenson, G. J., C. R. Yang, et al. (1988). Influence of dopamine on limbic inputs to the nucleus accumbens. Annuals of the New York Academy of Science, 537, 86-100. Moghaddam, B. and D. Javitt (2012). From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology, 37(1), 4-15. Moore, R. Y. (2003). Organization of midbrain dopamine systems and the pathophysiology of Parkinson’s disease. Parkinsonism Related Disorders, 9 Suppl 2, S65-71. Moskowitz, M. A., E. H. Lo, et al. (2010). The science of stroke: mechanisms in search of treatments. Neuron, 67(2), 181-198. Muller, K. R., M. Tangermann, et al. (2008). Machine learning for real-time single-trial EEG- analysis: from brain-computer interfacing to mental state monitoring. Journal of Neurosciece Methods, 167(1), 82-90. Munzar, P., Z. Justinova, et al. (2002). Differential involvement of 5-HT2A receptors in the discriminative- stimulus effects of cocaine and methamphetamine. European Journal of Pharmacology, 436(1-2), 75-82. Murase, S. (2014). A new model for developmental neuronal death and excitatory/inhibitory balance in hippocampus. Molecular Neurobiology, 49(1), 316-325. Nagatsu, T., M. Levitt, et al. (1964). Conversion of L-tyrosine to 3,4-dihydroxyphenylalanine by cell-free preparations of brain and sympathetically innervated tissues. Biochemistry & Biophysics Research Commun, 14, 543-549. Nagatsu, T. and L. Stjarnel (1998). Catecholamine synthesis and release. Overview. In D. S. Goldstein, G. Eisenhofer and R. McCarty (Eds.), Catecholamines bridging basic science with clinical medicine (pp. 1-14). San Diego: Academic Press. Nash, J. F. and B. K. Yamamoto (1992). Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain research, 581(2), 237- 243. Naylor, D. E., H. Liu, et al. (2005a). Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. The Journal of neuroscience, 25(34), 7724-7733. Naylor, D. E. and C. G. Wasterlain (2005b). GABA synapses and the rapid loss of inhibition to dentate gyrus granule cells after brief perforant-path stimulation. Epilepsia, 46 Suppl 5, 142- 147. Nestler, E. J. (2001). Molecular basis of long-term plasticity underlying addiction. Nature reviews. Neuroscience, 2(2), 119-128. Nicholls, D. and D. Attwell (1990). The release and uptake of excitatory amino acids. Trends in Pharmacological Sciences, 11(11), 462-468. Nicola, S. M., J. Surmeier, et al. (2000). Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annual Reviews in Neuroscience, 23, 185-215.